Suppr超能文献

磷酸酶抑制剂对人肺肥大细胞功能的调节

Regulation of human lung mast cell function by phosphatase inhibitors.

作者信息

Peachell P T, Munday M R

机构信息

Department of Medicine and Pharmacology, University of Sheffield, Royal Hallamshire Hospital, United Kingdom.

出版信息

J Immunol. 1993 Oct 1;151(7):3808-16.

PMID:7690815
Abstract

Okadaic acid, a cell-permeant inhibitor of serine/threonine phosphatases (PP) was found to attenuate the IgE-mediated release of both performed (histamine) and newly formed (leukotriene C4) mediators from human lung mast cells (HLMC). Optimal inhibition (82 +/- 6%) of the IgE-triggered release of histamine was observed after a 2-h incubation of HLMC with okadaic acid (1 microM). Shorter (< 2 h) incubation times and lower (< 1 microM) concentrations of okadaic acid were less effective at inhibiting histamine release from HLMC. The extent to which okadaic acid prevented histamine release was highly dependent upon the strength of the stimulus with lower levels of stimulation more readily modulated. The efficacy of okadaic acid as an inhibitor was not dependent upon the nature of the stimulus because matched levels of histamine release (approximately 30%) induced by either IgE-mediated processes or the calcium ionophore A23187 were attenuated to comparable extents. A series of analogues of okadaic acid and a structurally-distinct PP inhibitor, calyculin, were also found to inhibit the IgE-induced release of mediators from HLMC with the following rank order of potency; calyculin (approximate IC50; 0.015 microM) > okadaic acid (0.2 microM) > okadaol (3.3 microM) > nor-okadaone (> 10 microM). These same PP inhibitors displayed a similar rank order of activity for the inhibition of mediator release induced by the ionophore A23187. Extracts of purified HLMC were found to liberate 32P from radiolabeled glycogen phosphorylase and this PP activity was inhibited by both low (2 nM) and high (5 microM) concentrations of okadaic acid suggesting that HLMC contain both PP type 2A (PP2A) and PP type 1 (PP1). The okadaic acid, analogues of okadaic acid, and calyculin attenuated mediator release at concentrations and with a rank order of activity that closely parallels their activities as inhibitors of PP suggests that PP are important in the regulation of HLMC function. This contention is further supported by the finding that PP activities are constitutively associated with HLMC and that these activities could be inhibited by okadaic acid.

摘要

冈田酸是一种可透过细胞的丝氨酸/苏氨酸磷酸酶(PP)抑制剂,研究发现它能减弱人肺肥大细胞(HLMC)中预先形成的(组胺)和新形成的(白三烯C4)介质的IgE介导释放。在用冈田酸(1微摩尔)孵育HLMC 2小时后,观察到IgE触发的组胺释放受到最佳抑制(82±6%)。较短的孵育时间(<2小时)和较低的冈田酸浓度(<1微摩尔)对抑制HLMC释放组胺的效果较差。冈田酸阻止组胺释放的程度高度依赖于刺激强度,较低水平的刺激更容易被调节。冈田酸作为抑制剂的效果不依赖于刺激的性质,因为由IgE介导的过程或钙离子载体A23187诱导的组胺释放的匹配水平(约30%)都被减弱到相当的程度。还发现一系列冈田酸类似物和一种结构不同的PP抑制剂花萼海绵诱癌素能抑制HLMC中IgE诱导的介质释放,其效力顺序如下:花萼海绵诱癌素(近似IC50;0.015微摩尔)>冈田酸(0.2微摩尔)>冈田醇(3.3微摩尔)>去甲冈田酮(>10微摩尔)。这些相同的PP抑制剂在抑制离子载体A23187诱导的介质释放方面也表现出类似的活性顺序。发现纯化的HLMC提取物能从放射性标记的糖原磷酸化酶中释放32P,并且这种PP活性受到低浓度(2纳摩尔)和高浓度(5微摩尔)冈田酸的抑制,这表明HLMC同时含有2A型PP(PP2A)和1型PP(PP1)。冈田酸、冈田酸类似物和花萼海绵诱癌素在浓度和活性顺序上减弱介质释放,这与它们作为PP抑制剂的活性密切平行,表明PP在HLMC功能调节中很重要。PP活性与HLMC组成性相关且这些活性可被冈田酸抑制这一发现进一步支持了这一论点。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验